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ABSTRACT
The SOS response in Eubacteria is a global response
to DNA damage and its activation is increasingly as-
sociated with the movement of mobile genetic ele-
ments. The temperate phage GIL01 is induced into
lytic growth using the host’s SOS response to ge-
nomic stress. LexA, the SOS transcription factor, re-
presses bacteriophage transcription by binding to
a set of SOS boxes in the lysogenic promoter P1.
However, LexA is unable to efficiently repress GIL01
transcription unless the small phage-encoded pro-
tein gp7 is also present. We found that gp7 forms a
stable complex with LexA that enhances LexA bind-
ing to phage and cellular SOS sites and interferes
with RecA-mediated auto-cleavage of LexA, the key
step in the initiation of the SOS response. Gp7 did
not bind DNA, alone or when complexed with LexA.
Our findings suggest that gp7 induces a LexA confor-
mation that favors DNA binding but disfavors LexA
auto-cleavage, thereby altering the dynamics of the
cellular SOS response. This is the first account of an
accessory factor interacting with LexA to regulate
transcription.
INTRODUCTION
The SOS response is a highly conserved mechanism by
which bacteria identify and repair DNA damage inside the
cell (1). The two key components of the SOS response are
the recombinase RecA and the global transcription fac-
tor LexA (2,3). Under normal growth conditions, LexA re-
presses transcription of numerous DNA damage-inducible
genes by binding to an upstream DNA sequence termed
the SOS box. Upon DNA damage, RecA bound to single-
stranded DNA stimulates the autocatalytic cleavage of
LexA, thereby lifting repression of LexA-regulated genes,
including recA and lexA itself. LexA eventually restores the
repressed state as the DNA is repaired and levels of acti-
vated RecA drop.
In Escherichia coli, LexA directly regulates some 30 pro-
moters that direct the expression of genes involved in repair-
ing or replicating damagedDNA (4,5). LexA is increasingly
associated with regulating functions that are unrelated to
cell rescue (6). Examples are the movement of mobile ele-
ments (7,8), the propagation of virulence factors (9,10) and
the lytic cycle of temperate phages (11–14). Although LexA
is the master repressor of the SOS response, an in vivo study
of LexA binding sites in E. coli identified about 20 novel
targets that lacked a recognizable LexA binding motif and
failed to be bound by LexA in vitro. These sites are likely to
require an accessory factor for LexA binding (15).
Bacteriophage GIL01 infects the insect pathogen Bacil-
lus thuringiensis and establishes a stable, quiescent residence
within its host (16). While this lysogenic state is particularly
stable, GIL01 can efficiently switch to the lytic cycle in re-
sponse to DNA-damaging treatments. This is the case for
many temperate phages, best exemplified by phage lambda,
which take advantage of a conserved cellular DNA-damage
signaling pathway in order to escape a potentially doomed
host. Unlike most temperate phages, however, GIL01 does
not code for its own stress-sensitive repressor. Instead, our
results showed that stable lysogeny relies on the host tran-
scription factor LexA (17).
The GIL01 15-kb linear dsDNA genome does not inte-
grate into the host chromosome during lysogeny. All pre-
dicted ORFs in GIL01 are transcribed in the same left-to-
right direction, possibly as a means to minimize interfer-
ence between gene transcription and genome replication.
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The GIL01 genome is divided into two main modules: the
left 5-kb of the genome are dedicated to genome replication
and regulation while the right 10-kb code for virus struc-
tural and lytic functions (Figure 1A). Accordingly, two pro-
moter regions were identified upstream of each module. To
the left, P1 and P2 direct the expression of immunity and
replication genes whereas the internalP3 promoter controls
lytic gene expression (17). The tandem organization of P1
and P2 suggests that both promoters likely display distinct
strengths and are differentially regulated.
Using a genetic approach, we identified dinBox1, a 14-
bp long sequence in the P1 promoter region that is sim-
ilar to the consensus LexA binding site in Bacillus sub-
tilis (CGAAC(n)4GTTCG) (18,19). Mutants in dinBox1
were unable to establish a lysogenic state, suggesting that
dinBox1 functions as a LexA binding site and that LexA
binding is important for GIL01 lysogeny (17). This was
verified by generating a LexA-noncleavable mutant host,
lexA(A96D), that is deficient for the auto-proteolysis reac-
tion and thereby unable to induce the SOS response. GIL01
could not be induced in the lexA(A96D) host, confirming
that the host SOS pathway regulates GIL01 development.
This study also identified two small GIL01 gene products,
gp1 and gp7, required for stable lysogen formation. Gp1 is
very likely a DNA binding protein but a possible function
for gp7 was not found.
In this work, we report that host LexA directly regu-
lates phage gene expression from promoter P1. In addition
to binding to the predicted SOS site dinBox1, purified B.
thuringiensis LexA also binds to an adjacent non-canonical
sequence termed dinBox1b that appears to contain only one
LexA half-site (Figure 1A). Point mutations in the con-
served bases in either dinBox1 or dinBox1b significantly re-
duce LexA affinity and binding is nearly eliminated to a
doubly mutated probe. While the dinBox1 and dinBox1b
sites possibly overlap, our experiments indicate that LexA
binds to both sites in an independent, non-cooperativeman-
ner. In vitro, LexA binding to dinBox1b is unstable unless
the small phage-coded protein, gp7, is also provided. Gp7
alone does not bind to promoter DNA but specifically in-
teracts with immobilized LexA in the absence of DNA. In-
terestingly, the gp7-enhancing effect was also observed with
other cellular LexA targets, such as the SOS box directly up-
stream of the lexA gene. We provide evidence that gp7 sta-
bilizes LexA binding to bacteriophage as well as host SOS
boxes. Most importantly, we show that gp7 also interferes
with the RecA-mediated LexA auto-cleavage reaction. Our
results identify for the first time, a factor that directly inter-
acts with the major SOS transcription factor LexA to mod-
ulate the SOS response.
MATERIALS AND METHODS
Bacterial strains and culture conditions
Escherichia coli strain DH5 was routinely used for plas-
mid constructions destined to be transformed into B.
thuringiensis. Strain XL10-Gold (Stratagene) was used for
site-directed mutagenesis, and strains M15 [pREP4] (Qia-
gen) and BL21 (DE3) pLysE were used for protein expres-
sion, as described.
Bacillus thuringiensis serovar israelensis isogenic
strains GBJ002 and GBJ338 were used as GIL01-
cured and GIL01-lysogenic hosts, respectively (17). B.
thuringiensis strains GBJ396 [lexA(A96D)] and GBJ499
[recA::pMutin4] are GBJ002 derivatives mutated in the
lexA and recA genes, respectively (17).
Escherichia coli and B. thuringiensis strains were grown
in L-broth at 37◦C and 30◦C, respectively. To induce DNA
damage, mitomycin C (0.05 g/ml) was added to one-
half of mid-log phase cultures for 1 h at 30◦C. To in-
duce gp7 expression in Bacillus, 0.1 mM isopropyl -D-
thiogalactopyranoside (IPTG) was added to one-half of the
cultures and the other half was incubated in parallel to pro-
vide an uninduced control. After 1 h of induction, cultures
were stressed by addition of mitomycin C (0.05 g/ml) for
an additional hour.
Plasmid construction
The primers used in this study are listed in Supplementary
Table S1.
A P1–P2 promoter fusion to lacZ in the low-copy-
number shuttle vector pHT304–18Z was described previ-
ously (17). To examine expression from P1 alone, transcrip-
tion from P2 was eliminated using QuikChange Lightning
site-directed mutagenesis (Stratagene) to mutate the -10 site
from 5′-TAATAT to 5′-GAGCAC, generating pNF543. In
order to generate a promoter-free control, pNF543 was
used as template to eliminate P1 by replacing its −10 site
from 5′-TATAAT to 5′-GAGCAC. Mutations within the
LexA binding sites dinBox1 and dinBox1b were similarly
generated using pNF543 as a template. The promoter re-
gions upstream of lexA (coordinates 3 623 933 through 3
624 142 inB. cereus strain G9842; GenBank accession num-
ber NC 011772) and recA (coordinates 3 720 030 to 3 720
243 in strain G9842) were PCR amplified and the respec-
tive products were purified, restricted and ligated into the
HindIII–BamHI-digested pHT304–18Z vector. The result-
ing lacZ promoter constructs were transformed into strains
GBJ002 [lexA+] and GBJ396 [lexA(A96D)] for analysis of
-galactosidase expression. Transformation was done by
electroporating Bacillus electrocompetent cells with 0.5 g
plasmid DNA in 2 mm cuvettes at 25 Fa, 1.4 kV and 400
.
The ORF7 expression plasmid pDG7 was as previously
described (17). pDG7was transformed intoGBJ002 [lexA+]
strains harboring lacZ promoter fusions. Control strains
contained lacZ promoter fusions along with the empty vec-
tor pDG148.
Bacillus lexA (coordinates 3 624 082 through 3 624 714 in
strain G9842), ORF1 (GIL01 coordinates 356 through 532;
GenBank accession number AJ536073) and ORF7 (GIL01
coordinates 4564 through 4716) were PCR amplified using
primers flanked by BamHI and HindIII restriction sites, di-
gested and cloned into expression vector pQE-30 (Qiagen),
downstream of the IPTG-inducible T5 promoter.
Bacillus recA (coordinates 3 719 029 through 3 720 060 in
strain G9842) was PCR amplified using primers flanked by
BamHI and MluI restriction sites, digested and cloned into
expression vector pET8c (Novagen) to generate pRecABc.
The constructs were verified by DNA sequencing. All four
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Figure 1. P1 is regulated by host LexA. (A) Genetic map of GIL01 with the P1–P2 promoter region enlarged below. Transcription start sites of the tandem
promotersP1 andP2 are depicted with angled arrows (middle schematic) and shown in boldface letters (+1; bottom schematic). The−35 and−10 promoter
consensus sequences are represented in black and LexA binding sites dinBox1 and dinBox1b are shown in gray. The beginning of ORF1 is indicated by
a full arrow. Nucleotide substitutions used to generate promoter and SOS box mutant fusions to the lacZ gene are indicated by stippled lines above the
respective promoter sequence. The boundaries of probes used in DNase I footprint experiments (Figures 2C and 4) are delineated below the map. (B) A
P1+P2−-lacZ fusion was generated by inactivating promoter P2with four substitutions to its−10 sequence (left panel). The resulting lacZ fusion was then
used to generate single nucleotide mutations in dinBox1 (middle panel) or dinBox1b (right panel) that are expected to eliminate or greatly reduce LexA
binding to the respective site. Beta-galactosidase activity was measured in both lexA+ and lexA(A96D) phage-cured strains (−GIL01) and lysogen strains
(+GIL01), under normal growth conditions (−MMC) and under SOS-inducing conditions (+MMC). Activities (Miller units) are the average of at least
three independent experiments. MMC50 (0.05 g/ml) is a mitomycin C concentration sufficiently high to elicit an SOS response (Supplementary Figure
S1).
genes were expressed as recombinant proteins with an N-
terminal His6 epitope tag.
Overexpression and purification of His6-LexA and His6-gp7
Escherichia coliM15 [pREP4], containing the lexA, gp1 or
gp7 gene fusion, was grown in 500 ml L-broth containing
ampicillin (150 g/ml) and kanamycin (25 g/ml). Protein
expression was induced at an OD600 of 0.7 by the addition
of 1 mM IPTG. After 3 h at 30◦C, the cells were harvested
by centrifugation, resuspended in 50 mM NaH2PO4 and
0.3 M NaCl (buffer A) containing 10 mM imidazole, and
lysed by addition of lysozyme to 0.1 mg/ml. His6-LexA,
His6-gp1 and His6-gp7 were purified from cell lysates by
passing them over a Ni-nitrilotriacetic acid (NTA) column
pre-equilibrated with buffer A containing 10 mM imida-
zole. The column was washed extensively with the same
buffer, followed by buffer A containing 20 mM imidazole.
His-tagged proteins were eluted with buffer A containing
250mM imidazole. Fractions containing the over-expressed
proteins, as determined by SDS-PAGE, were concentrated
on Amicon Ultra-15 centrifugal filter units with a 3-kDa
(His6-gp1 and His6-gp7) or 10-kDa (His6-LexA) cut-off
(Millipore), buffer exchanged into 50 mM Tris–HCl, pH
7.5, 1 mMEDTA, 50 mMNaCl, 7 mM -mercaptoethanol
and stored in 50% glycerol at –80◦C.
Preparation of recombinant RecA protein
To induce the synthesis of RecA protein, an overnight cul-
ture of E. coli BL21 (DE3) pLysE strain harboring pRe-
cABc was grown in 500 ml L-broth containing ampicillin
(100 g/ml) and chloramphenicol (25 g/ml), to an OD600
of 0.6 when 0.8 mM IPTG was added to the culture. After
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Figure 2. LexA binds to dinBox1 and to half-site dinBox1b. (A) Band shift assays of His6-LexA binding to probes encompassing dinBox1 and dinBox1b.
Nucleotide sequences are detailed under each panel and positions that are known to be important for LexA binding are shown in uppercase letters.
Mutations are shown in red. The upper strand of each probe was 5′ end-labeled prior to hybridization with the unlabeled complementary bottom strand.
In each panel, the His6-LexA concentrations are 0, 0.25, 0.5, 1, 2, 8 nM and 16 nM (lanes 7 and 20). Labeled but non-hybridized oligonucleotides are visible
at the bottom of each gel. (B) SPR analysis of the His6–LexA interaction with immobilized DNA fragments containing wild-type or mutated dinBox sites.
His6–LexA in a concentration range of 2.5–20 nMwas injected across the chip-immobilized DNA fragments (∼50 RU) for 60 s at a flow rate of 100l/min.
The dissociation phase was followed for 540 s. Protein concentrations are denoted above the sensorgrams and operator sequences are presented above each
graph with mutated nucleotides shown in red. The experiments were performed in triplicate and representative sensorgrams are shown. RU, response units.
(C) DNase I footprint analysis of LexA binding to dinBox1 and dinBox1b. DNA fragments extending from positions −39 to +176 relative to the start of
P1 transcription (see Figure 1A) were 32P-labeled at the 5′-end of the top strand, incubated with His6-LexA, and digested with DNase I. Cleavage products
were separated on an 8% sequencing gel. G+A marker lanes contain the same wild-type probe chemically cleaved at guanosine and adenosine residues.
The four probes used for footprint analysis contained: the wild-type P1 promoter sequence, a mutation in dinBox1, a mutation in dinBox1b or mutations
in both dinBox1 and dinBox1b (see Figure 1A for SOS box nucleotide sequences). The first lane corresponding to each probe is labeled DNA without
added protein. The following His6-LexA protein concentrations were used: 20, 80 and 320 nM. SOS box sequences are indicated in the left margin and the
nucleotide positions that were substituted to generate the dinBox1 and dinBox1b mutated probes are indicated by an asterisk. The P1 transcription start
site is denoted with an angled arrow and the −10 sequence is indicated. Arrows in the right margin indicate the positions of DNase I hypersensitivity sites.
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4 h, the cells were harvested and the cell pellet was stored at
–20◦C. The recombinant RecA protein was synthesized in-
soluble in inclusion bodies. The cells were resuspended at 1 g
wet mass/ml in lysis buffer (50mMNaH2PO4, 0.3MNaCl,
10 mM imidazole, pH 8.0), supplemented with lysozyme
(0.5 mg/ml), DNAse (10 g/ml), RNAse (20 g/ml), ben-
zamidine (1 mM), AEBSF (0.5 mM), PMSF (0.5 mM) and
sonicated (vibracell, Sonics) at 40% amplitude 6 times for
20 s. The homogenate was centrifuged at 26 000 × g for
30 min at 4◦C. Inclusion bodies were washed in 20 mM
Tris–HCl, 0.5 M NaCl, 2% (v/v) Triton X-100, pH 8.0,
sonicated and centrifuged twice and stored at -20◦C. The
RecA protein was dissolved in 20 mM Tris–HCl, 0.5 M
NaCl, 6 M guanidinium chloride, 5 mM imidazole, 5 mM
-mercaptoethanol, pH 8.0 (2 ml buffer/g inclusion body
wet mass) by stirring for 1 h at 4◦C. To refold the recom-
binant RecA, the dissolved protein was diluted 100-fold in
20 mM Tris–HCl, 0.5 M NaCl, 5 mM imidazole, 5 mM -
mercaptoethanol, pH 8.0, at 4◦C. The refolded protein was
concentrated using Amicon Ultra-15 centrifugal filter units
with a 10-kDa cut-off (Millipore). The concentration of re-
combinant RecA protein was determined using NanoDrop
1000 (Thermo Scientific) and the extinction coefficient at
280 nm was 15 930/M/cm.
RecA*-dependent LexA repressor self-cleavage assay
Recombinant RecA (10 M) was activated with the S1
primer (2.2 M) (Supplementary Table S1), 2 mM MgCl2
and 1 mM ATP- -S as described (20) for 2 h on ice. The
LexA repressor (2.1 M) was either free or pre-incubated
with gp7 (8.6 M) for 3 min at 37◦C. Cleavage reactions
were performed in 20 mM Tris (pH 7.4), 5 mM MgCl2, 1
mM ATP- -S, 1 mM DTT, 60 mM NaCl, 0.6 mM imida-
zole, 1 mM -mercaptoethanol, 0.15 mM EDTA and 15%
glycerol at 37◦C. The last five components came from the
addition of RecA and gp7 storage buffers and were also
added to reaction mixtures without gp7. The reaction time
course was initiated by the addition of activated RecA fila-
ments (RecA at 2 M in 20 l reaction mixtures) or by the
addition of inactive RecA filaments formed in the absence
of ssDNA and ATP- -S. All reactions were stopped by ad-
dition of NuPAGE LDS sample buffer (Invitrogen). Sam-
ples were analyzed on 15% SDS-PAGE gels and stained by
Page blue protein stain (Thermo Scientific). The resolved
bands were quantified as described (21).
Surface plasmon resonance assays
SPRmeasurements were performed on a Biacore T100 (GE
Healthcare) at 25◦C. The streptavidin sensor chip SA (GE
Healthcare) was washed with a 60 s injection of 50 mM
NaOH and 1 M NaCl and equilibrated in SPR buffer (25
mM Tris–HCl [pH 7.3], 140 mM NaCl, 5 mM EDTA, 2
mM dithiothreitol (DTT), 0.1 mg/ml BSA, 0.005% sur-
factant P20). Approximately 30 response units (RU) of 3′-
biotinylated S1 primer (Supplementary Table S1) was im-
mobilized on the flow cells of the streptavidin chip. To pre-
pare double-stranded DNA fragments with P1 promoter
or lexA operator sequences, or their derivatives with modi-
fied SOS boxes, complementary primers denoted as primer
name u and primer name d in 20 mM Tris–HCl (pH 7.5),
140 mM NaCl were mixed in a 1:1.5 (mol:mol) ratio, re-
spectively. Primers were annealed using a temperature gra-
dient from 94◦C to 4◦C (∼1.5 h) in a PCR machine (Ep-
pendorf). The resulting 40–42-bp duplex DNA, with a 15
nucleotide single-strand 5′ overhang complementary to the
SPR chip-immobilized S1 primer, was passed for 1–5 min
at 2 l/min across the flow cell 2, immobilizing 30 to 60
RU of DNA fragment. The interaction between His-tagged
LexA, gp7 or LexA pre-incubated with gp7 for a few min-
utes at room temperature, and the chip-immobilized DNAs
was analyzed by injecting solutions of the desired protein
concentrations in SPR buffer at 100 l/min. Regeneration
of the sensor surface was performed with 50 mMNaOH for
10 s.
To study the kinetics of the LexA-gp7 interaction, His-
tagged gp7 or LexA in 7 mM Na2HPO4 (pH 4), 12.5
mM KH2PO4, 140 mM NaCl were covalently coupled to
the surface of the sensor flow cell activated with 0.4 M
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 0.1M
N-hydroxysuccinimide. Excess reactive groupswere blocked
with ethanolamine. Either His-tagged LexA, gp1 or gp7
proteins were used as analytes. Kinetic measurements were
performed using sensor chip CM5 (GEHealthcare) at 25◦C
at a flow rate of 30 l/min in SPR buffer. Regeneration of
the sensor surface was performed with 1 mMNaOH for 15
s.
Electrophoretic mobility shift assay
Probes described in Figure 3 were amplified by PCR from
GBJ338 genomicDNA, gel-purified and 5′-end labeledwith
[ -32P] ATP and T4 polynucleotide kinase (NEB). Probes
described in Figure 2A were constructed by hybridizing
oligonucleotides, in which one nucleotide was 5′-end labeled
and gel-purified prior to hybridization. Binding assays were
performed by incubating different amounts of His6-LexA,
in the presence or absence of 340 nMHis6-gp7, with approx-
imately 1 nM radiolabeled duplex oligonucleotides or 0.25
nM radiolabeled 200-bp PCR products in binding buffer
(80 mM NaCl, 25 mM Tris [pH 7.5], 5 mM EDTA, 2 mM
DTT, 0.1 mg/ml BSA, 0.05 g/l poly(dI-dC)). Reactions
were incubated for 30 min at room temperature prior to
loading directly onto native 6% (w/v) polyacrylamide gels.
Electrophoresis was carried out at room temperature for 1.5
h at 30 mA using 1× TAE as the running buffer. Gels were
dried directly to blotting paper and exposed to autoradio-
graphic film.
DNase I footprint analysis
Probes for DNase I footprints were generated by PCR us-
ing primers flanking the P1 promoter region (Figure 1A).
The primer complementary to the template strand was 5′-
end labeled with [ -32P] ATP and T4 polynucleotide kinase
(NEB). PCR amplification products were purified from
1.2% agarose gels using the QIAquick Gel Extraction Kit
(Qiagen). Binding reactions with varying amounts of pu-
rified His6–LexA or His6–LexA plus His6–gp7 were per-
formed using the same binding conditions as for the gel-
shift assays in a total volume of 20 l. Reactions were incu-
bated for 30 min at room temperature followed by addition
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Figure 3. Gp7 forms a complex with LexA bound to the dinBox sites. Electrophoretic mobility shift assay of His6–LexA (8 nM) and His6–gp7 (340 nM)
binding to 5′ end-labeled DNA probes extending from −25 to +176 relative to the start of P1 transcription. The three probes used are identical except for
single nucleotide mutations (shown in red) in dinBox1 (lanes 5–8) and dinBox1b (lanes 9–12) that eliminate LexA binding to the respective site.
of DNase I (0.1 U) (Promega) for 4 min. The DNase I re-
action was terminated by the addition of 20 mM EDTA,
50 mM NaCl, 0.1 mg/ml tRNA and 1% SDS. The DNA
products were ethanol precipitated, resuspended in loading
buffer (50% formamide, 50% ddH2O, 0.01% xylene cyanol,
0.01% bromophenol blue) and heated at 90◦C for 1–2 min
prior to loading onto 8% sequencing gels (9 M urea). An
A+G ladder was made by formic acid modification of the
radiolabeled DNA, followed by piperidine cleavage (22).
-Galactosidase assays
-Galactosidase assays were performed as described pre-
viously (17). Bacillus strains transformed with lacZ fusion
plasmids were grown to exponential phase in L-broth con-
taining 10 g/ml erythromycin, at which point MMC (0.05
g/ml) was added to one-half of the cultures. Cultures were
incubated for one additional hour, and samples (20l) were
taken and assayed as described. In strains where pDG7 was
also present, 10 g/ml kanamycin was included in the cul-
tures. To induce gp7 expression from the inducible spac pro-
moter, 0.1 mM IPTG was added to the cultures 1 h prior to
MMC induction.
RESULTS
Transcription from promoter P1 is regulated by host LexA
and phage-borne factors
We previously showed that LexA controlled GIL01 gene
transcription by fusing promoters P1 and P2 to the E.
coli lacZ reporter gene and analyzing LacZ expression in
B. thuringiensis (17). A P1–P2–lacZ fusion was tightly re-
pressed in a lysogen and expression could be induced ∼4-
fold in SOS conditions. Accordingly, there was no induc-
tion of transcription from the same promoter fusion in an
SOS-deficient lexA(A96D) host, indicating that LexA reg-
ulates P1–P2 expression, most likely by directly binding to
the predicted SOS box dinBox1 (Figure 1A). Considering
the close proximity of dinBox1 to P1, centered at +17 from
the start of P1 transcription, we investigated the possibility
that LexA regulates expression from P1. For that, we inac-
tivated P2 by replacing its -10 TAATAT box with the se-
quence GAGCAC to generate a P1+P2− promoter fusion.
We also constructed a control fusion, P1− P2−, in which
both the P1 and P2 promoters were inactivated in a similar
manner. As expected, this fusion did not show promoter ac-
tivity in B. thuringiensis (5.65 ± 4.13 Miller units), indicat-
ing that the −10 box substitutions abolish promoter activ-
ity from both P1 and P2. Figure 1B (left panel) shows that
in a host lacking GIL01, P1+P2− activity is induced ∼2-
fold in stress conditions (+MMC). The same P1+P2−-lacZ
fusion is strongly repressed in a GIL01 lysogen (5.7-fold),
and expression is lifted to normal levels upon SOS induc-
tion (+MMC). As expected, P1+P2− activity is repressed in
a non-inducible lexA(A96D) host and cannot be induced
in stress conditions, regardless of the presence or absence
of a resident phage. Moreover, P1+P2− repression is notice-
ably stronger in the lexA(A96D)GIL01-lysogen than in the
phage-cured host. These results identified P1 as the LexA-
repressed promoter.
To confirm that dinBox1 is the target of LexA-mediated
regulation, we introduced a single nucleotide substitution
at a conserved position that is known to be important for
LexA binding (18). As can be seen from Figure 1B (middle
panel), the dinBox1-mutated P1 fusion shows high consti-
tutive expression in a non-lysogen and is no longer SOS-
inducible by MMC treatment, suggesting that LexA no
longer recognizes this mutated dinBox. However, the same
fusion is moderately repressed and induced in aGIL01 lyso-
gen strain, indicating that P1 is also regulated by unknown
phage factors in an SOS-dependent fashion. Introduction
of this fusion into the LexA(A96D) strain blocks this induc-
tion, indicating that this phage-dependent repression must
somehow require LexA binding to dinBox1. These obser-
vations lead us to investigate a hypothesis that unknown
phage-encoded factors are somehow ‘assisting’ host LexA
in repressing P1 expression in lysogens.
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LexA binds to dinBox1 and to a downstream non-canonical
site termed dinBox1b
To investigate the binding of LexA to dinBox1, B.
thuringiensis LexA was over-expressed in E. coli as a 6xHis-
tidineN-terminal fusion protein and used in electrophoretic
mobility shift assays (EMSA) with radiolabeled oligonu-
cleotide probes containing the P1 promoter region. As
shown in Figure 2A, His6–LexA formed a doublet with the
wild-type probe (Figure 2A, lanes 1–7), consistent with the
existence of two LexA binding sites in our DNA probe. In-
spection of the probe sequence revealed a second potential
binding site containing only one conserved LexA-binding
‘half-site’, termed dinBox1b. A mutant probe carrying a
single G-T mutation at a highly conserved position in din-
Box1 eliminated the faster-migrating form but retained the
slower-migrating shifted form in EMSA experiments (Fig-
ure 2A, lanes 8–13). The slower-migrating complex was ev-
ident only at high His6-LexA concentrations and appeared
to breakdown during gel electrophoresis, suggesting that
LexA binds to dinBox1b with significantly lower affinity
than it does to dinBox1. In contrast, when EMSA was
performed with a probe mutated at dinBox1b, the faster-
migrating complex was still observed but not the slower-
migrating form (Figure 2A, lanes 14–20). A doublymutated
probe could not be shifted by His6-LexA (Figure 2A, lanes
21–26). The mutant probes, which in each case eliminated
respective LexA binding, were designed using the known
consensus sequence for LexA binding in other bacterial
species, leading us to conclude that B. thuringiensis LexA
makes similar important and specific protein:DNA con-
tacts. We did not observe a third, slower-migrating species
that would indicate LexA binding simultaneously to both
dinBox sites. Either the close proximity of dinBox1 and din-
Box1b prevents dual binding or this complex was not ob-
served in EMSA for unknown reasons.
Surface plasmon resonance (SPR) analysis validated our
EMSA results. His6–LexA interacted with the wild-type op-
erator targets in a concentration-dependent manner (Fig-
ure 2B). Association of His6-LexA with an immobilized
DNA fragment carrying either single or double nucleotide
changes in dinBox1 was still detectable but was unstable, in-
dicating that dinBox1b is a low-information-content-site. In
contrast, a strong and very stable LexA-DNA interaction
was observed when theDNA fragment contained amutated
dinBox1b operator (Figure 2B), indicating that dinBox1 is
indeed a high-affinity binding site. These data show that
LexA is capable of binding independently to the potentially
overlapping sites dinBox1 and dinBox1b in the P1 promoter
region and that there are noticeable differences in the affin-
ity and stability of binding at each site.
Since dinBox1b can function as a LexA-binding site, we
assessed its role in regulating gene expression from P1 by
studying a lacZ fusion with a nucleotide substitution in the
dinBox1b half-site (Figure 1A) in the cured and lysogenic
hosts (Figure 1B, right panel). LacZ assays showed that
expression levels from a dinBox1b mutant were higher in
the cured and lysogenic lexA+ strains compared with the
wild-type fusion, indicating that LexA repression is slightly
lifted when dinBox1b is mutated but SOS-induction levels
are maintained. We conclude that dinBox1b plays a minor
but detectable role in P1 transcription in vivo.
LexA protects a sequence encompassing dinBox1 and din-
Box1b
In order to physically define the LexA binding sites in the
P1 promoter region, DNase I protection assays were per-
formed using radiolabeled wild-type or mutant DNA frag-
ments (sequences are shown in Figure 1A). Figure 2C shows
protection data obtained with the wild-type promoter se-
quence as well as derivatives mutated in either dinBox1,
dinBox1b or in both sites simultaneously. As can be seen
for the wild-type probe (lanes 1–4), the location and ex-
tent of protection with increasing concentrations of His6-
LexA are consistent with His6–LexA binding to both din-
Box1 and dinBox1b. Full occupancy of the dinBox1 site oc-
curred at 320 nM His6-LexA, whereas at the same LexA
concentration, dinBox1b is only partially protected (Figure
2C, lane 4). In addition, DNase I hypersensitive sites were
detected at the boundaries of (positions +26 to +27 and
+43) and within the dinBox1b site (positions +33 to +34,
shown with arrows in Figure 2C), indicating that local dis-
tortions or bends of the DNA result from His6-LexA bind-
ing. Curiously, the extent of His6–LexA binding to dinBox1
differs from that observed for dinBox1b. Considering that
the Bacillus LexA dimer binds to a 14-bp sequence, the ex-
pected length of a footprint would be 18–20 bp. This is the
case for dinBox1 but not for dinBox1b, for which the pro-
tected sequence corresponds to ∼14 bp, raising the possi-
bility that His6-LexA does not bind to dinBox1b DNA in
the same manner. Alternatively, the dinBox1 and dinBox1b
sites overlap and prevent simultaneous binding of twoLexA
dimers.
Compared to a wild-type probe, His6-LexA
binding to a probe mutated in dinBox1 (CGAA-
CaagcTTTTTataagtGTTCG, mutation shown in bold)
is considerably reduced (Figure 2C, compare lanes 5–8
to lanes 1–4). Using the same probe, His6-LexA binding
to dinBox1b is unchanged, except for the loss of one
hypersensitive site within dinBox1b (at positions +33 to
+34) that is associated with LexA binding to dinBox1.
A point mutation in dinBox1b (CGAACaagcGTTT-
TataagtGTTCA) significantly interferes with His6-LexA
binding to the dinBox1b site while binding to dinBox1
remains unchanged (Figure 2C, compare lanes 9–12 to
lanes 1–4). However, the hypersensitive site within din-
Box1b (at positions +33 to +34) is restored, consistent
with this hypersensitive site being associated with LexA
binding to dinBox1. A dinBox1–dinBox1b double mutant
(CGAACaagcTTTTTataagtGTTCA) showed no specific
interaction with His6–LexA (Figure 2C, lanes 13–16).
Taken together with the EMSA results (Figure 2A), the
DNase I footprint analysis leads us to conclude that His6-
LexA binds independently to dinBox1 and dinBox1b and
thatHis6-LexA binding is associated withDNAdistortions.
Gp7 interacts with LexA at dinBox1 and dinBox1b
Since a P1-lacZ fusion is more strongly repressed in a lyso-
gen than in the cured host (Figure 1B, left panel), we sus-
pected that, in addition to LexA, phage factors might also
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Figure 4. DNase I footprint analysis showing enhanced LexA binding to dinBox1 and dinBox1b in the presence of gp7. DNA fragments extending from
−39 to +176 relative to the start of P1 transcription (see Figure 1A) were 32P-labeled at the 5′ end of the top strand, incubated with His6-LexA or His6–
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be involved in the regulation of P1. In a previous study, an
additional class of GIL01 clear-plaque mutants had been
isolated in ORF7, coding for a small protein of unknown
function (17). Complementation studies showed that ORF7
was essential for GIL01 to enter the lysogenic state. To ex-
plore the possible role of gp7 in GIL01 regulation, ORF7
was over-expressed in E. coli as an N-terminal 6xHis fu-
sion and used in EMSA experiments. Although His6–gp7
did not bind to a DNA probe encompassing the P1 region,
His6-gp7 gave rise to a slower-migrating novel form when
added to reactions together withHis6-LexA (Figure 3). This
interaction persistedwhen theDNAprobes weremutated in
dinBox1 (lanes 5–8) or dinBox1b (lanes 9–12), although the
intensity of the interaction was diminished with a dinBox1-
mutated probe and was weakest with a probe mutated at
the dinBox1b site. These results suggest that gp7 can form
a ternary complex with LexA bound at dinBox1 or at din-
Box1b.
Gp7 increases the apparent binding capacity of LexA for din-
Box1 and dinBox1b
In DNase I footprints (Figure 4), His6-gp7 alone did not
protect a DNA probe encompassing promoter P1 (Figure
4A, lane 8). However, when His6–gp7 was added to the
DNA probe along with His6–LexA, His6–gp7 clearly stabi-
lized LexA binding to dinBox1 and dinBox1b (Figure 4A,
lanes 9–14). In particular, His6-gp7 greatly increased ap-
parent binding affinity of His6–LexA to dinBox1b. Binding
to dinBox1 improved only slightly upon addition of His6-
gp7. Overall, the presence of His6–gp7 resulted in His6-
LexA occupying dinBox1 and dinBox1b at markedly lower
LexA concentrations (Figure 4A, lanes 8–14). We extended
these observations by testing the ability of His6–gp7 to pro-
mote His6-LexA binding to DNA probes mutated in din-
Box1 and/or dinBox1b. DNase I footprint analysis showed
that when dinBox1 carried a single nucleotide mutation that
does not entirely abolish His6–LexA binding, His6–gp7 was
still seen to enhance His6–LexA binding to dinBox1 by ap-
proximately two-fold (Figure 4B). Similar to what we ob-
served with the wild-type probe, addition of His6–gp7 re-
sulted in His6–LexA occupying both sites at significantly
lower LexA concentrations. In contrast, when the probe is
mutated in dinBox1b, the effect of His6–gp7 on LexA bind-
ing at dinBox1b site is barely detectable (Figure 4C). A dou-
bly mutant probe is no longer bound by His6–LexA and
the enhancing effect of His6–gp7 is only detectable at the
highest His6–LexA concentrations (Figure 4D, lanes 13 and
14). Again, we did not observe DNase I protections that
would indicate gp7 making direct contacts with P1 pro-
moter DNA. Altogether, these results suggest that His6-gp7
does not make direct DNA contacts but instead cooperates
with His6-LexA to enhance DNA binding. This could be
the case if gp7 favored a LexA conformation that is better
suited for DNA binding.
To provide further insights into this interaction, we used
SPR to measure the gp7 effect on LexA–DNA binding. Pu-
rified His6–gp7, at a concentration of 300 nM, did not ap-
pear to directly interact with any of the DNA fragments
used in SPR analysis (Figure 5). However, it strongly en-
hanced His6-LexA DNA binding capacity for the streptavi-
dine (SA) chip-immobilized DNA fragment carrying din-
Box1 and dinBox1b (Figure 5A). An increased His6-gp7
effect on LexA binding capacity was also observed when
His6-gp7was added togetherwithHis6-LexA to an immobi-
lizedDNA fragment harboring a pointmutation in dinBox1
(Figure 5B). In contrast, His6–gp7 hadmarkedly smaller ef-
fect on His6-LexA binding when dinBox1 was eliminated
due to the change of two conserved nucleotides in dinBox1
(Figure 5C). When either single or double mutations were
introduced into dinBox1b, addition of His6–gp7 could not
restore optimal LexA binding, as observed for the wild-type
fragment in presence of His6–gp7 (Figure 5D and E). We
determined that His6–gp7, in the concentration range of
75–300 nM, had similar effects on His6–LexA binding and
therefore, a His6–gp7 concentration of 300 nM was used
in all subsequent SPR experiments (Supplementary Figure
S2). The SPR data showed that His6–gp7 enhances LexA
binding to both dinBox sites but not to the non-specific
DNA (Figure 5F). We hypothesize that phage factor gp7
modulates LexA DNA binding affinity by stabilizing a spe-
cific repressor conformation (21). We also measured the
effect of His6–gp7 on His6–LexA binding to the known
SOS box upstream of B. thuringiensis lexA, or its mutant
variant containing three nucleotide substitutions. LexA in-
teracted with the wild-type operator in a concentration-
dependent manner and the complexes were highly stable.
Interaction with the mutated DNA probe was detectable
but the complexes were markedly unstable (Supplementary
Figure S3). SPR analysis confirmed thatHis6–gp7 enhances
LexA binding to both DNA fragments.
To further show that gp7 stabilizes LexAbinding toDNA
targets, we pre-incubated His6–LexA and His6–gp7 and
then injected them over the chip-immobilized DNA frag-
ment harboring wild-type dinBox sites and followed the dis-
sociation of the resulting nucleoprotein complexes. Data
showed that subsequent injection of additional His6–gp7
prevented His6–LexA from dissociating off the DNA frag-
ment (Supplementary Figure S4A). Collectively, our results
strongly suggest that gp7 interacts with LexA to enhance its
DNA binding affinity at a variety of target sites.
Gp7 interacts with free LexA repressor
The direct interaction of LexA with another protein has
not been described yet. Thus, to investigate the possibility
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LexA plus His6–gp7, and digested with DNase I. Cleavage products were separated on an 8% sequencing gel. G+A marker lanes contain the respective
probes chemically cleaved at guanosine and adenosine residues. Lane 1 is probe DNA without added protein. His6–LexA concentrations in lanes 2–7 and
9–14 are 10, 20, 40, 80, 160 and 320 nM. In lanes 8–14, His6–LexA was pre-incubated with the DNA probe prior to addition of 340 nM His6–gp7. SOS
box sequences are indicated in the left margin and the nucleotide positions that were substituted to generate the dinBox1 and dinBox1b mutated probes
are indicated by an asterisk. The P1 transcription start site is denoted with an angled arrow and the -10 sequence is indicated. Arrows in the right margin
denote DNase I hypersensitivity sites. His6–LexA and His6–gp7 binding was studied to wild-type (A), mutated dinBox1 (B), mutated dinBox1b (C) and
mutated dinBox1-dinBox1b (D) probes. The G+A marker in (B) corresponds to the wild-type probe and not the dinBox1 mutant probe.
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Figure 5. SPR analysis of the gp7 interaction with LexA bound to the dinBox sites. (A–F) SPR sensorgrams showing the interaction of His6–LexA and
His6–gp7, alone or combined, with a DNA fragment carrying dinBox1 and dinBox1b. Proteins were injected across each chip-immobilized DNA fragment
(∼60 RU) for 210 s at a flow rate of 100 l/min. Protein concentrations are denoted above the sensorgrams and operator sequences are presented above
each graph with mutated nucleotides shown in red. The experiments were performed in triplicate and representative sensorgrams are shown (See also
Supplementary Figures S2, S3 and S4).
of a direct interaction between LexA and gp7, we injected
the purified His6-gp7 in different concentrations across the
chip-immobilizedB. thuringiensisLexA repressor, in the ab-
sence of any DNA. SPR analysis shows that His6–gp7 and
His6–LexA interacted with high affinity, exhibiting an ap-
parent equilibrium dissociation constant (KD) of 17.7 nM
for the predicted stoichiometry of one gp7 monomer per
LexA monomer (Figure 6A and B). The specificity of the
interaction was further confirmed by the absence of interac-
tion between LexA and another phage-borne protein, pre-
dicted DNA binding protein gp1 (Supplementary Figure
S4B). When the experiment was reversed and His6–gp7 was
immobilized onto the surface of the CM5 chip, no interac-
tion with free His6–LexA was detected, which suggests that
the entire surface of His6–gp7must be exposed for the inter-
action to occur (Supplementary Figure S4B). We conclude
that gp7 directly interacts with the LexA repressor, likely
changing its conformation in a way that enhances LexA
binding affinity for its target DNA.
Since His6–gp7 interacts with His6-LexA, we reasoned
that such an interaction could interfere with RecA-
mediated LexA auto-cleavage. To investigate this, activated
RecA filaments were pre-formed with ATP and ssDNA,
and added to His6-LexA that had been pre-incubated with
His6–gp7 at approximately one LexA dimer per eight gp7
monomers. Proteolytic cleavage of His6–LexA was moni-
tored by SDS-PAGE. These results showed that His6-gp7
moderately inhibits the rate of RecA-catalyzed LexA auto-
cleavage, compared to the rate of LexA inactivation when
tested in the absence of His6–gp7 (Figure 6C and D). No
His6–LexA cleavage was visible in the presence of inactive
RecA (without addition of ATP and ssDNA) (Supplemen-
tary Figure S5). Our data suggest that viral protein gp7 can
directly modulate the bacterial SOS response via a previ-
ously undescribed mechanism, by direct protein interaction
with LexA repressor.
Gp7 represses promoter P1 and prevents its SOS induction in
vivo
In order to assess the role of gp7 in P1 transcription in vivo,
ORF7 was cloned downstream of the inducible spac pro-
moter in pDG148, a vector capable of replicating in Bacil-
lus (17). We determined the effect of gp7 expression on a
P1+P2−-lacZ fusion in the GIL01 host, B. thuringiensis. As
can be seen in Figure 7A, the spac promoter is leaky and
strong repression of P1+P2− was observed in the absence
of IPTG induction. Previous studies indeed showed that the
spac promoter on multicopy vector pDG148 directs basal
levels of transcription in the absence of inducer (23,24). In-
duction of gp7 expression by addition of IPTG (0.1 mM) to
growing cells resulted in increased repression of P1. When
mitomycin C was added to the cultures expressing gp7 in
7326 Nucleic Acids Research, 2015, Vol. 43, No. 15
Figure 6. Gp7 reduces the rate of LexA auto-proteolysis in the presence of activated RecA. (A) SPR sensorgram of His6–gp7 interaction with immobilized
His6–LexA. His6–gp7 was injected in a concentration range of 1.6-50 nM and flowed across the chip-immobilized LexA (∼2000 RU) for 360 s at a rate
of 30 l/min. The dissociation phase was followed for 420 s. (B) Determination of the apparent equilibrium dissociation constant (KD) from the plot
of response as a function of His6–gp7 concentration injected across His6–LexA. For this analysis, we assumed a stoichiometry of one gp7 monomer per
LexA monomer. The dotted line indicates an apparent KD for His6–gp7 binding to His6–LexA of approximately 17.7 nM. (C) Time course of His6–LexA
auto-proteolysis in the presence of RecA-ATP filaments. LexA was pre-incubated with gp7 in a molar ratio of ∼1:4 (LexA monomer:gp7 monomer) and
added to pre-formed RecA-ATP filaments (2 M). The inhibition of LexA auto-proteolysis by gp7 was monitored by SDS-PAGE. Quantitation of each
auto-cleavage reaction is shown above the respective band as the ratio (%) of the protein density value of the initial sample (0 min) relative to the density
value obtained from the proteins after 5, 12, 20 or 40 min after addition of the active RecA filament, together with the standard error of the mean. Intact
LexA monomer (LexA), C-teminal or N-terminal LexA fragments (CTD/NTD) and RecA protein are marked accordingly. Experiments were performed
in duplicate and a representative gel is shown. (See also Supplementary Figure S5.) (D) Graphical representation of intact LexA resulting from incubation
with activated RecA, with or without gp7, as presented in panel (C).
presence of the P1+P2−-lacZ fusion, P1 repression was not
lifted as we observed for the same fusion in a normal lyso-
gen host (Figure 1B, left panel). This result shows that gp7
over-expression strongly enhances repression ofP1 and also
prevents induction of P1 by SOS, likely through its interac-
tion with host LexA.
To confirm that gp7 repression of P1 is LexA-dependent,
we analyzed the effect of gp7 expression on a P1+P2− -
lacZ fusionmutated in dinBox1 (Figure 7A).We know from
EMSA and DNase I footprint experiments that His6–LexA
affinity for a mutated dinBox1 site is considerably weakened
and that addition of His6–gp7 only slightly improves His6-
LexA binding. In vivo, gp7 has a modest effect on a P1+P2−
dinBox1mut-lacZ fusion (similar to the repression levels ob-
served with a same fusion in a GIL01-lysogen, Figure 1B),
indicating that binding of LexA to dinBox1 is required to
observe gp7-mediated repression. Taken together, these re-
sults show that gp7 prevents SOS-activation of P1 by acting
at the level of LexA.
In order to determine if the gp7-mediated repression
extends to other cellular SOS genes, similar experiments
were carried out using lexA and recA promoter fusions to
lacZ. As shown in Figure 7B, over-expression of gp7 in B.
thuringiensis did not noticeably enhance LexA-mediated re-
pression of lexA and recA, but gp7 expression did inhibit
their SOS induction. These results confirmed that gp7 can
act as an accessory factor of host LexA and thereby, inhibit
the induction of the SOS response.
DISCUSSION
Our previous results suggested a direct role for LexA in reg-
ulating transcription from theGIL01 tandem promotersP1
and P2 (17). Here we show that LexA specifically binds
to and regulates promoter P1 and is assisted by GIL01-
encoded gp7 in repressing transcription. LexA binds to two
sites downstream of promoter P1 but does not efficiently
repress P1 transcription unless gp7 is also provided. We
found that gp7 enhances LexA binding to operator DNA
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Figure 7. Expression of gp7 in B. thuringiensis enhances LexA-mediated
repression at promoter P1 and prevents SOS gene induction. (A) Beta-
galactosidase activity from a P1+P2−-lacZ fusion was measured in the
absence (−IPTG) or presence (+IPTG) of gp7 in B. thuringiensisGBJ002.
After 1 h of IPTG (0.1 mM) induction, the cells were treated withMMC50
for 1 h in order to elicit the SOS response. pDG148 is the insert-free vec-
tor used as control and pDGP7 is the pDG148 vector expressing gp7.
Note that the spac promoter is leaky in B. thuringiensis (P1+P2−/pDG7;
−IPTG). Upon induction of gp7 expression (+IPTG), P1+P2− repression
by gp7 is similar to that observed in the lysogen (Figure 1B, left panel).
Data represent mean ± S.D. from three independent replicates, and statis-
tical significance was by two-tailed t test (P values: *, <0.05; **, <0.005;
***,<0.0005; and ****,<10−6). (B) Same experiment as in (A) using lexA
and recA promoter fusions.
by forming stable complexeswith free orDNA-boundLexA
through a direct physical interaction. Gp7 does not appear
to contain a known DNA binding domain and none of
our data suggest that gp7 makes direct contact with the
DNA. Most importantly, expression of gp7 inhibits induc-
tion of the host SOS response and, in vitro, impairs RecA-
stimulated proteolysis of LexA. This study identifies for the
first time a factor that interacts with the SOS repressor,
LexA, to increase its affinity for DNA and inhibit its auto-
cleavage.
Host LexA binds to a noncanonical site in phage GIL01
Our EMSA and footprinting studies show that LexA binds
to two distinct sites located downstream of theP1 transcrip-
tion start. While dinBox1 nearly matches the LexA bind-
ing motif found in Gram-positive bacteria (25), dinBox1b
only displays a single recognizable half-site. A mutation in
dinBox1 results in the loss of LexA regulation and com-
mits GIL01 to exclusively carry out the lytic cycle. In con-
trast, the dinBox1b mutation has little effect on LexA regu-
lation and no lytic mutants were isolated in dinBox1b (17).
In agreement with the relative importance of both sites in
vivo, our mobility shift assays and SPR analysis show that
LexA has high affinity for dinBox1 while binding to the din-
Box1b half-site is noticeably unstable. In E. coli, LexA pri-
marily exists as a dimer that recognizes a DNA sequence
of inverted symmetry (26,27). The LexA dimer was shown
to be able to bind to operator half-sites, but it did so with
considerably lower affinity (28). This could also be the case
for B. thuringiensis LexA repressor and would explain the
poor affinity for dinBox1b as well as a shorter footprint
at dinBox1b (Figure 2C). One LexA monomer might bind
the cognate half-site specifically, while the other monomer
binds operator DNA non-specifically.
One intriguing observation in EMSA experiments is the
absence of an apparent third shifted form representing dou-
bly bound probe, with LexA bound simultaneously to din-
Box1 and dinBox1b. It is possible that LexA binding to din-
Box1b generates DNA distortions that are not compatible
with simultaneous LexA occupation of both sites. We also
considered the possibility of cooperative binding at dinBox1
and dinBox1b. Considering that dinBox1b is a weak-affinity
site, one might expect LexA binding to the higher affin-
ity site, dinBox1, to provide the cooperative energy that as-
sists LexA binding to dinBox1b. However, our in vitroDNA
binding results suggest that there is no cooperativity be-
tween bound LexA dimers and even questions the possibil-
ity of simultaneous LexA binding to both sites.
LexA binding is assisted by phage-borne gp7
A previous study in E. coli, using chromatin immunopre-
cipitation coupled with high-density microarrays, reported
LexA binding to noncanonical SOS box sites. Since LexA
binding appeared to be overall restricted to biologically rel-
evant sites, the authors hypothesized that LexA is likely
to cooperate with an accessory factor to enable binding at
these poorly conserved sites (15).We identified phage-borne
gp7 as a factor cooperating with B. thuringiensis LexA. In
our experiments, gp7 did not appear to interact directly with
the DNA but formed a ternary complex with LexA and its
cognate binding sites. Gp7 interacting with LexA, but with-
out contacting the DNA, would constitute a unique exam-
ple of a transcription accessory factor in bacteria. Tran-
scription factors cooperating to regulate transcription are
typically DNA binding proteins that prevent or facilitate
RNAP-promoter binding by direct interaction or indirectly,
by modifying the DNA topology. One well-documented
example is the cooperative interaction between the global
transcription regulator cAMP receptor protein (CRP) and
CytR in E. coli (29). Both are DNA binding proteins but
CytR cannot stably bind to promoter DNA by itself: effi-
cient DNA binding of CytR relies on co-binding with CRP-
cAMP. The binding of one protein increases the affinity of
the other protein for an adjacent binding site through spe-
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cific protein:DNA and protein:protein interactions. Simi-
larly, CRP andMelR need to cooperate in order to increase
DNA occupancy by MelR and efficiently activate down-
stream gene transcription (30). In other systems, such as the
B. subtilis lytic phage phi29, transcription regulator p4 in-
teracts with histone-like protein p6 to form a hairpin struc-
ture that is instrumental in the early-to-late gene transcrip-
tion switch (31).
Here, gp7 augments the binding affinity of LexA for con-
served sites but appears to assist even more in LexA bind-
ing to poorly conserved sites such as dinBox1b. As a result,
there is much tighter repression of promoter activity as well
as impaired SOS induction of the LexA/gp7-regulated pro-
moter. It is noteworthy that gp7 influences LexA binding to
neighboring sites, such as at promoter P1, as well as to iso-
lated LexA operators, such as those found upstream of recA
and lexA, suggesting that the promoter-SOS box configura-
tion, i.e. the number and distribution of the SOS boxes, is
not a determining factor for gp7 activity. Since we provide
evidence of a direct LexA-gp7 physical interaction, the next
question we asked is how gp7 influences LexA function.
Since LexA essentially exists as a dimer in the cell, the func-
tion of gp7 is not to improve dimer formation but to favor
DNAbinding by affecting the conformation of LexA. LexA
monomers dimerize by the carboxyterminal domain (CTD)
(32) and bind to specific DNA sequences via a helix-turn-
helix in the amino-terminal domain (NTD) (33). Previous
studies showed that a reorientation of the LexADNA bind-
ing NTD with respect to the CTD was necessary for sta-
ble and specific operator binding (34,35). It is possible that
gp7 somehow favors this reorientation and by doing so, in-
duces the non-cleavable conformation of LexA. Gp7 could
influence LexA binding by interacting with its N-terminus
or the hinge that connects the NTD to the CTD (36). Like-
wise, LexA auto-cleavage could be prevented by gp7 directly
interfering with the RecA-ssDNA interaction. The current
structural model in E. coli shows that activated RecA fila-
ment interacts with whole LexA (37), offering many LexA-
gp7 interaction possibilities that would impede access to
RecA. More studies, including elucidating the structure of
the LexA-gp7 complex, are required in order to shed light
on the nature of this interaction.
The dynamics of the SOS response
LexA regulates the lytic cycle of several phages, usually by
repressing the expression of anti-immunity factors (12–14)
but rarely by directly controlling the expression of phage
propagation genes (11). Here, LexA directly regulates the
lytic cycle of GIL01 by binding to both conserved and
poorly conserved operators with the help of a phage-borne
accessory factor. Gp7 not only stabilizes LexA binding but
also inhibits the RecA-catalyzed auto-proteolysis of LexA,
a step that is critically important to initiate lytic growth of
GIL01. GIL01, unlike phage lambda, does not code for its
own SOS-sensitive repressor but uses host LexA to con-
trol lytic and lysogenic gene expression (17). In lambda, CI
cleavage in response to genomic stress occurs at a slower
rate than LexA cleavage (38), possibly in a bid to ensure
that the phage cycle is only induced once the cell is no
longer able to address DNA damage. If GIL01 lytic genes
were regulated by LexA alone, stable lysogeny would only
be achieved through high LexA affinity for its sites or an
important number of sites, such that the phage is only in-
duced in response to a significant SOS signal. By express-
ing gp7, GIL01 might ensure that the lytic cycle is stably
repressed in normal growth conditions and induced only in
response to a persistent DNA damage signal. The effect of
gp7 on the host cellular response to genomic stress, on the
other hand, would have considerable impact on the host’s
cell biology. By delaying or impairing the SOS response,
gp7 would modulate the response that senses DNA damage
and would therefore affect cell repair and survival. Since we
observed that gp7 was strongly expressed during SOS in-
duction (Supplementary Figure S6), a delay or inhibition
of the SOS response is very likely to occur. By expressing
gp7, GIL01 determines the timing and extent of the SOS
response, playing an important role in cell fate.
We only found gp7 homologues in tectivirus genomes
that are related to GIL01 (Supplementary Figure S7).
Therefore, it seems that peptides with a similar function
are rare and only found in phage genomes. This fits within
the view of bacteriophages coding for functions that coopt
the host into following the phage developmental program.
Other phages code for their own sigma factors and DNA
metabolism proteins (T4) (39), addiction systems (P1) (40),
quorum sensing genes (41), all with the purpose of con-
trolling the host metabolic machinery for their own benefit.
This study describes a phage-encoded protein that specifi-
cally interferes with the host SOS DNA repair pathway.
Since LexA continues to be the subject of numerous stud-
ies because of its important role in the cell, and the in-
sights it provides into regulatory circuits of higher organ-
isms, a fuller description of our findings will have impor-
tant consequences for understanding the dynamics of the
SOS response. Essentially, gp7 is a promising inhibitor of
the SOS response by virtue of its strong interaction with B.
thuringiensis LexA repressor.
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